# Holley Inc.: financial statements, quarterly

HLLY · NYSE · CIK 1822928 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hlly.md) · [Financials](/companies/hlly/financials.md) · [Filings](/companies/hlly/filings.md) · [Insiders](/companies/hlly/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hlly/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [157](/filings/0001437749-24-034047.md) | [156 d](/filings/0001437749-25-007614.md) | [159](/filings/0001437749-25-014913.md) | [169](/filings/0001628280-25-038097.md) | [134](/filings/0001628280-25-050421.md) | [140 d](/filings/0001628280-26-018218.md) | [153](/filings/0001822928-26-000017.md) | [167](/filings/0001822928-26-000068.md) | [138](/filings/0001628280-25-050421.md) | [155 d](/filings/0001628280-26-018218.md) | [147](/filings/0001822928-26-000017.md) | [172](/filings/0001822928-26-000068.md) |
| Cost of revenue | $m | [98.2](/filings/0001437749-24-034047.md) | [95.5 d](/filings/0001437749-25-007614.md) | [107](/filings/0001437749-25-014913.md) | [99.2](/filings/0001628280-25-038097.md) | [81.7](/filings/0001628280-25-050421.md) | [76.2 d](/filings/0001628280-26-018218.md) | [89.0](/filings/0001822928-26-000017.md) | [97.1](/filings/0001822928-26-000068.md) | [78.5](/filings/0001628280-25-050421.md) | [82.7 d](/filings/0001628280-26-018218.md) | [86.6](/filings/0001822928-26-000017.md) | [101](/filings/0001822928-26-000068.md) |
| Gross profit | $m | [58.4](/filings/0001437749-24-034047.md) | [60.3 d](/filings/0001437749-25-007614.md) | [52.1](/filings/0001437749-25-014913.md) | [70.3](/filings/0001628280-25-038097.md) | [52.3](/filings/0001628280-25-050421.md) | [63.9 d](/filings/0001628280-26-018218.md) | [64.1](/filings/0001822928-26-000017.md) | [69.6](/filings/0001822928-26-000068.md) | [59.8](/filings/0001628280-25-050421.md) | [72.8 d](/filings/0001628280-26-018218.md) | [60.7](/filings/0001822928-26-000017.md) | [70.5](/filings/0001822928-26-000068.md) |
| Research and development | $m | [6.1](/filings/0001437749-24-034047.md) | [4.9 d](/filings/0001437749-25-007614.md) | [4.8](/filings/0001437749-25-014913.md) | [4.3](/filings/0001628280-25-038097.md) | [4.6](/filings/0001628280-25-050421.md) | [5.0 d](/filings/0001628280-26-018218.md) | [4.1](/filings/0001822928-26-000017.md) | [5.1](/filings/0001822928-26-000068.md) | [4.7](/filings/0001628280-25-050421.md) | [4.9 d](/filings/0001628280-26-018218.md) | [4.0](/filings/0001822928-26-000017.md) | [3.7](/filings/0001822928-26-000068.md) |
| Selling, general and administrative | $m | [28.9](/filings/0001437749-24-034047.md) | [32.2 d](/filings/0001437749-25-007614.md) | [33.0](/filings/0001437749-25-014913.md) | [34.6](/filings/0001628280-25-038097.md) | [30.1](/filings/0001628280-25-050421.md) | [34.5 d](/filings/0001628280-26-018218.md) | [36.7](/filings/0001822928-26-000017.md) | [33.0](/filings/0001822928-26-000068.md) | [33.5](/filings/0001628280-25-050421.md) | [43.0 d](/filings/0001628280-26-018218.md) | [35.4](/filings/0001822928-26-000017.md) | [40.4](/filings/0001822928-26-000068.md) |
| Operating income | $m | [19.3](/filings/0001437749-24-034047.md) | [18.8 d](/filings/0001437749-25-007614.md) | [10.2](/filings/0001437749-25-014913.md) | [27.9](/filings/0001628280-25-038097.md) | [5.6](/filings/0001628280-25-050421.md) | [(29.0) d](/filings/0001628280-26-018218.md) | [19.3](/filings/0001822928-26-000017.md) | [27.5](/filings/0001822928-26-000068.md) | [15.9](/filings/0001628280-25-050421.md) | [19.8 d](/filings/0001628280-26-018218.md) | [17.5](/filings/0001822928-26-000017.md) | [2.8](/filings/0001822928-26-000068.md) |
| Interest expense | $m | [13.7](/filings/0001437749-23-030772.md) | [18.8 d](/filings/0001437749-24-007848.md) | [11.0](/filings/0001437749-24-015204.md) | [13.2](/filings/0001628280-25-038097.md) | [15.0](/filings/0001628280-25-050421.md) | [11.5 d](/filings/0001628280-26-018218.md) | [15.7](/filings/0001822928-26-000017.md) | [13.4](/filings/0001822928-26-000068.md) | [11.3](/filings/0001628280-25-050421.md) | [11.5 d](/filings/0001628280-26-018218.md) | [9.9](/filings/0001822928-26-000017.md) | [8.2](/filings/0001822928-26-000068.md) |
| Income tax | $m | [2.1](/filings/0001437749-24-034047.md) | [0.6 d](/filings/0001437749-25-007614.md) | [(0.9)](/filings/0001437749-25-014913.md) | [2.1](/filings/0001628280-25-038097.md) | [(1.5)](/filings/0001628280-25-050421.md) | [(2.7) d](/filings/0001628280-26-018218.md) | [1.1](/filings/0001822928-26-000017.md) | [3.5](/filings/0001822928-26-000068.md) | [1.3](/filings/0001628280-25-050421.md) | [3.6 d](/filings/0001628280-26-018218.md) | [1.9](/filings/0001822928-26-000017.md) | [(1.2)](/filings/0001822928-26-000068.md) |
| Net income | $m | [0.8](/filings/0001437749-24-034047.md) | [1.2 d](/filings/0001437749-25-007614.md) | [3.7](/filings/0001628280-25-050421.md) | [17.1](/filings/0001628280-25-050421.md) | [(6.3)](/filings/0001628280-25-050421.md) | [(37.8) d](/filings/0001628280-26-018218.md) | [2.8](/filings/0001822928-26-000068.md) | [10.9](/filings/0001822928-26-000068.md) | [(0.8)](/filings/0001628280-25-050421.md) | [6.3 d](/filings/0001628280-26-018218.md) | [7.3](/filings/0001822928-26-000068.md) | [(2.4)](/filings/0001822928-26-000068.md) |
| Diluted EPS | $ per share | [0.01](/filings/0001437749-24-034047.md) | not reported | [0.03](/filings/0001437749-25-014913.md) | [0.14](/filings/0001628280-25-038097.md) | [(0.05)](/filings/0001628280-25-050421.md) | not reported | [0.02](/filings/0001822928-26-000017.md) | [0.09](/filings/0001822928-26-000068.md) | [(0.01)](/filings/0001628280-25-050421.md) | not reported | [0.06](/filings/0001822928-26-000017.md) | [(0.02)](/filings/0001822928-26-000068.md) |
| Basic EPS | $ per share | [0.01](/filings/0001437749-24-034047.md) | not reported | [0.03](/filings/0001437749-25-014913.md) | [0.14](/filings/0001628280-25-038097.md) | [(0.05)](/filings/0001628280-25-050421.md) | not reported | [0.02](/filings/0001822928-26-000017.md) | [0.09](/filings/0001822928-26-000068.md) | [(0.01)](/filings/0001628280-25-050421.md) | not reported | [0.06](/filings/0001822928-26-000017.md) | [(0.02)](/filings/0001822928-26-000068.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-01) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [36.8](/filings/0001437749-23-030772.md) | [41.1](/filings/0001437749-25-007614.md) | [41.1](/filings/0001437749-24-015204.md) | [53.1](/filings/0001437749-24-025177.md) | [50.8](/filings/0001437749-24-034047.md) | [56.1](/filings/0001628280-26-018218.md) | [39.1](/filings/0001437749-25-014913.md) | [63.8](/filings/0001628280-25-038097.md) | [50.7](/filings/0001628280-25-050421.md) | [37.2](/filings/0001822928-26-000068.md) | [33.1](/filings/0001822928-26-000017.md) | [69.0](/filings/0001822928-26-000068.md) |
| Current assets | $m | [305](/filings/0001437749-23-030772.md) | [297](/filings/0001437749-25-007614.md) | [290](/filings/0001437749-24-015204.md) | [301](/filings/0001437749-24-025177.md) | [299](/filings/0001437749-24-034047.md) | [297](/filings/0001628280-26-018218.md) | [288](/filings/0001437749-25-014913.md) | [303](/filings/0001628280-25-038097.md) | [316](/filings/0001628280-25-050421.md) | [316](/filings/0001822928-26-000068.md) | [318](/filings/0001822928-26-000017.md) | [331](/filings/0001822928-26-000068.md) |
| Total assets | $m | [1,219](/filings/0001437749-23-030772.md) | [1,203](/filings/0001437749-25-007614.md) | [1,192](/filings/0001437749-24-015204.md) | [1,198](/filings/0001437749-24-025177.md) | [1,184](/filings/0001437749-24-034047.md) | [1,133](/filings/0001628280-26-018218.md) | [1,144](/filings/0001437749-25-014913.md) | [1,158](/filings/0001628280-25-038097.md) | [1,165](/filings/0001628280-25-050421.md) | [1,164](/filings/0001822928-26-000068.md) | [1,179](/filings/0001822928-26-000017.md) | [1,162](/filings/0001822928-26-000068.md) |
| Current liabilities | $m | [88.9](/filings/0001437749-23-030772.md) | [93.7](/filings/0001437749-25-007614.md) | [102](/filings/0001437749-24-015204.md) | [108](/filings/0001437749-24-025177.md) | [102](/filings/0001437749-24-034047.md) | [95.2](/filings/0001628280-26-018218.md) | [101](/filings/0001437749-25-014913.md) | [104](/filings/0001628280-25-038097.md) | [114](/filings/0001628280-25-050421.md) | [115](/filings/0001822928-26-000068.md) | [100](/filings/0001822928-26-000017.md) | [108](/filings/0001822928-26-000068.md) |
| Total liabilities | $m | [781](/filings/0001437749-23-030772.md) | [762](/filings/0001437749-25-007614.md) | [747](/filings/0001437749-24-015204.md) | [735](/filings/0001437749-24-025177.md) | [725](/filings/0001437749-24-034047.md) | [712](/filings/0001628280-26-018218.md) | [720](/filings/0001437749-25-014913.md) | [720](/filings/0001628280-25-038097.md) | [725](/filings/0001628280-25-050421.md) | [715](/filings/0001822928-26-000068.md) | [723](/filings/0001822928-26-000017.md) | [713](/filings/0001822928-26-000068.md) |
| Long-term debt | $m | [604](/filings/0001437749-23-030772.md) | [577](/filings/0001437749-25-007614.md) | [560](/filings/0001437749-24-015204.md) | [549](/filings/0001437749-24-025177.md) | [549](/filings/0001437749-24-034047.md) | [545](/filings/0001628280-26-018218.md) | [544](/filings/0001437749-25-014913.md) | [543](/filings/0001628280-25-038097.md) | [529](/filings/0001628280-25-050421.md) | [516](/filings/0001822928-26-000068.md) | [531](/filings/0001822928-26-000017.md) | [519](/filings/0001822928-26-000068.md) |
| Current portion of debt | $m | [6.6](/filings/0001437749-23-030772.md) | [7.5](/filings/0001437749-25-007614.md) | [7.4](/filings/0001437749-24-015204.md) | [7.4](/filings/0001437749-24-025177.md) | [7.5](/filings/0001437749-24-034047.md) | [7.2](/filings/0001628280-26-018218.md) | [7.1](/filings/0001437749-25-014913.md) | [6.9](/filings/0001628280-25-038097.md) | [6.7](/filings/0001628280-25-050421.md) | [6.6](/filings/0001822928-26-000068.md) | [6.6](/filings/0001822928-26-000017.md) | [8.2](/filings/0001822928-26-000068.md) |
| Shareholders' equity | $m | [438](/filings/0001437749-24-034047.md) | [441](/filings/0001628280-26-018218.md) | [445](/filings/0001628280-25-050421.md) | [463](/filings/0001628280-25-050421.md) | [459](/filings/0001628280-25-050421.md) | [421](/filings/0001822928-26-000068.md) | [425](/filings/0001822928-26-000068.md) | [438](/filings/0001822928-26-000068.md) | [440](/filings/0001628280-25-050421.md) | [449](/filings/0001822928-26-000068.md) | [456](/filings/0001822928-26-000068.md) | [450](/filings/0001822928-26-000068.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [22.5 d](/filings/0001437749-24-034047.md) | [31.2 d](/filings/0001437749-25-007614.md) | [18.8](/filings/0001437749-25-014913.md) | [25.7 d](/filings/0001628280-25-038097.md) | [(1.7) d](/filings/0001628280-25-050421.md) | [4.1 d](/filings/0001628280-26-018218.md) | [(7.9)](/filings/0001822928-26-000017.md) | [40.5 d](/filings/0001822928-26-000068.md) | [7.4 d](/filings/0001628280-25-050421.md) | [6.2 d](/filings/0001628280-26-018218.md) | [(2.9)](/filings/0001822928-26-000017.md) | [47.1 d](/filings/0001822928-26-000068.md) |
| Capital expenditure | $m | [1.7 d](/filings/0001437749-24-034047.md) | [1.5 d](/filings/0001437749-25-007614.md) | [1.3](/filings/0001437749-25-014913.md) | [1.4 d](/filings/0001628280-25-038097.md) | [1.7 d](/filings/0001628280-25-050421.md) | [2.4 d](/filings/0001628280-26-018218.md) | [3.0](/filings/0001822928-26-000017.md) | [4.8 d](/filings/0001822928-26-000068.md) | [2.1 d](/filings/0001628280-25-050421.md) | [2.4 d](/filings/0001628280-26-018218.md) | [3.5](/filings/0001822928-26-000017.md) | [6.2 d](/filings/0001822928-26-000068.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-02) | Q1 FY2023 (2023-04-02) | Q2 FY2023 (2023-07-02) | Q3 FY2023 (2023-10-01) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [117](/filings/0001437749-23-030772.md) | [117](/filings/0001437749-24-015204.md) | [118](/filings/0001437749-24-025177.md) | [119](/filings/0001437749-24-034047.md) | [120](/filings/0001437749-25-014913.md) | [119](/filings/0001628280-25-038097.md) | [119](/filings/0001628280-25-050421.md) | [120](/filings/0001822928-26-000017.md) | [120](/filings/0001822928-26-000068.md) | [119](/filings/0001628280-25-050421.md) | [122](/filings/0001822928-26-000017.md) | [120](/filings/0001822928-26-000068.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 121,234,143 at 2026-08-03, from the cover of the [10-Q filed 2026-08-05](/filings/0001822928-26-000068.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.